

Personalized Psychiatry with Hans Eriksson
Mar 27, 2024
In this engaging discussion, Hans Eriksson, Chief Medical Officer at HMNC Brain Health, shares insights into precision psychiatry aimed at creating personalized treatment plans for depression. He addresses the power of predictive diagnostics and genetics in improving outcomes. The conversation highlights innovative antidepressants and breakthrough AI-driven tools that have the potential to reshape mental health care. Eriksson also discusses the critical role of biomarkers like ABCB1 and the exciting research into HPA axis-targeted therapies.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7
Intro
00:00 • 2min
Advancing Precision in Psychiatry
01:32 • 4min
Revolutionizing Clinical Documentation and Understanding HPA Axis Dysfunction
05:19 • 2min
Targeting the HPA Axis: New Advances in Depression Treatment
07:25 • 5min
Exploring Dosing Strategies for New Depression Treatments
12:27 • 3min
Innovations in AI-driven Companion Diagnostics for Psychiatry
15:11 • 2min
Innovations in Personalized Psychiatry and Clinical Trials
17:19 • 3min